Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Elion Therapeutics, Inc.

Clinical trials sponsored by Elion Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New weekly shot could fight deadly mould infections with fewer side effects Results expected Dec 2026 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • New weekly shot could fight deadly mould infections with fewer side effects

    Disease control Recruiting now

    This Phase 2 trial tests whether a new drug called EL219 (Turletricin) is safe and effective for early treatment of invasive mould infections in people with weakened immune systems, such as those who have had a bone marrow transplant. About 60 participants will receive either EL2…

    Phase 2 • Sponsor: Elion Therapeutics, Inc. • Aim: Disease control

    Last updated Sep 05, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space